Provided by Tiger Trade Technology Pte. Ltd.

PepGen Inc.

1.74
+0.07004.19%
Volume:29.61K
Turnover:51.21K
Market Cap:120.26M
PE:-0.82
High:1.75
Open:1.72
Low:1.69
Close:1.67
52wk High:7.80
52wk Low:1.01
Shares:69.12M
Float Shares:45.78M
Volume Ratio:0.85
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1234
EPS(LYR):-2.1234
ROE:-67.39%
ROA:-36.03%
PB:0.82
PE(LYR):-0.82

Loading ...

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), PepGen Inc. (PEPG) and Omeros (OMER)

TIPRANKS
·
Apr 01

PepGen Shares Fall After Data From Ongoing Phase 2 Study for Myotonic Dystrophy Type 1 Patients

MT Newswires Live
·
Apr 01

PepGen Is Maintained at Outperform by Wedbush

Dow Jones
·
Mar 31

Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG) and IDEAYA Biosciences (IDYA)

TIPRANKS
·
Mar 31

Top Premarket Decliners

MT Newswires Live
·
Mar 31

Wedbush Cuts Price Target on PepGen to $5 From $9, Keeps Outperform Rating

MT Newswires Live
·
Mar 31

Stifel Nicolaus Sticks to Its Buy Rating for PepGen Inc. (PEPG)

TIPRANKS
·
Mar 31

Stocks to Watch: PepGen, Phreesia, Virgin Galactic

Dow Jones
·
Mar 31

PepGen Shares Fall on Mixed Trial Results for Muscle Disorder Drug

Dow Jones
·
Mar 31

PepGen down 46% at $2.30 after Phase 2 Freedom trial data

TIPRANKS
·
Mar 31

PepGen reports ‘promising’ topline results from MAD cohort

TIPRANKS
·
Mar 31

PepGen Inc trading halted, news pending

TIPRANKS
·
Mar 31

PepGen says Phase 2 FREEDOM2 DM1 trial shows favorable safety at 5 mg/kg dose

Reuters
·
Mar 31

PepGen Inc - Pgn-Edodm1 Well-Tolerated With No Serious Adverse Events Reported

THOMSON REUTERS
·
Mar 31

PepGen Announces Topline Results From Lowest Dose (5 Mg/Kg) Mad Cohort in the Ongoing Phase 2 Freedom2 Study Demonstrating Favorable Safety, Splicing and Vhot Data

THOMSON REUTERS
·
Mar 31

PepGen Inc - on Track to Report 10 Mg/Kg Cohort Data in 2H 2026; Cash Runway Into 2H 2027

THOMSON REUTERS
·
Mar 31

NASDAQ TRADE HALT HALT NEWS PENDING AT 04:01 PM

Reuters
·
Mar 31

Wedbush Sticks to Its Buy Rating for PepGen Inc. (PEPG)

TIPRANKS
·
Mar 23

Top Midday Decliners

MT Newswires Live
·
Mar 06

Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG) and Compass Therapeutics (CMPX)

TIPRANKS
·
Mar 05